Demineralized Bone Matrix Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Demineralized Bone Matrix Market size was valued at USD 832.8 million in 2023 and is estimated to grow at a CAGR of 4.9% from 2024 to 2032. Demineralized bone matrix (DBM) is a biologic material derived from human or animal bone tissue that has undergone a process to remove its mineral content, primarily calcium salts. DBM retains the structural integrity and biological properties of natural bone tissue, making it a valuable option in various medical applications, particularly in orthopedic and dental surgeries.
The rising prevalence of orthopedic disorders has emerged as a significant public health concern worldwide. For instance, according to the World Health Organization (WHO), in July 2022, around 1.71 billion people were affected by musculoskeletal conditions worldwide. Therefore, there is an increasing demand for advanced treatments such as demineralized bone matrix in orthopedic surgeries to facilitate bone healing and reconstruction.
Furthermore, growing technological advancements in demineralized bone matrix are expected to propel the growth of the market in the forthcoming years. These include innovations such as bone growth stimulators, a USD 875.2 million industry in 2021. The increasing patient base is also a contributing factor to the market expansion.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Demineralized Bone Matrix Market size in 2023: | USD 832.8 Million |
Forecast Period: | 2024 - 2032 |
Forecast Period 2023 - 2032 CAGR: | 4.9 |
2023 Value Projection: | USD 1.3 Billion |
Historical Data for: | 2018 - 2023 |
No of Pages: | 178 |
Tables, Charts & Figures: | 221 |
Segments Covered: | Product Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Technological advancements in demineralized bone matrix play a significant role in orthopedic and dental fields. These advancements aim to improve bone healing, increase surgical precision, enhance biocompatibility, and promote better integration with host tissues, leading to improved patient outcomes and reduced complications.
Based on product type, the market is classified into gel, putty sponge, fiber, paste, and other product types. The gel segment held a market size of USD 112.1 million in 2023.
Based on application, the demineralized bone matrix market is bifurcated into dental applications, craniomaxillofacial, joint reconstruction, spinal fusion, and other applications. The joint reconstruction segment is estimated to account for a market size of USD 280 million by 2032.
Based on end-use, the demineralized bone matrix market is categorized into hospitals, ambulatory surgical centers, specialty clinics, and other end-users. The hospitals segment accounted for around USD 364.4 million revenue in 2023.
North America demineralized bone matrix market accounted for USD 337.5 million revenue in 2023 and is predicted to witness substantial market growth.
The demineralized bone matrix industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced devices based on different technologies is a key market strategy. Some of the leading industry players including, RTI Surgical, Inc., Stryker, Medtronic plc among others have a notable presence in the market.
Some of the eminent market participants operating in the demineralized bone matrix industry include:
Market, By Product Type
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries:
Institut Straumann AG, Johnson & Johnson, Medtronic plc, RTI Surgical, Inc., Seaspine Holdings Corporation, Stryker Corporation, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc., are some of the major demineralized bone matrix companies worldwide.
North America demineralized bone matrix industry reached USD 337.5 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the presence of a sophisticated healthcare infrastructure and rising prevalence of orthopedic conditions in the region.
The gel segment recorded USD 112.1 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its ability to adhere to surrounding tissues and bone surfaces, thereby increasing the stability and longevity of the graft at site.
Demineralized bone matrix market size was USD 832.8 million in 2023 and is expected to register 4.9% CAGR from 2024-2032 owing to the rising prevalence of orthopedic disorders emerging, as a significant public health concern worldwide.